These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30291589)

  • 1. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes.
    Giugliano D; Maiorino MI; Bellastella G; Esposito K
    J Endocrinol Invest; 2019 May; 42(5):495-503. PubMed ID: 30291589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
    Ali SN; Dang-Tan T; Valentine WJ; Hansen BB
    Adv Ther; 2020 Feb; 37(2):869-882. PubMed ID: 31925649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
    Khunti K; Gomes MB; Pocock S; Shestakova MV; Pintat S; Fenici P; Hammar N; Medina J
    Diabetes Obes Metab; 2018 Feb; 20(2):427-437. PubMed ID: 28834075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
    Khunti K; Millar-Jones D
    Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
    Reach G; Pechtner V; Gentilella R; Corcos A; Ceriello A
    Diabetes Metab; 2017 Dec; 43(6):501-511. PubMed ID: 28754263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management.
    Grant R; Adams AS; Trinacty CM; Zhang F; Kleinman K; Soumerai SB; Meigs JB; Ross-Degnan D
    Diabetes Care; 2007 Apr; 30(4):807-12. PubMed ID: 17259469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.
    Giugliano D; Maiorino MI; Bellastella G; Esposito K
    Endocrine; 2018 Jul; 61(1):23-27. PubMed ID: 29322300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
    Ampudia-Blasco FJ; Palanca A; Trillo JL; Navarro J; Real JT
    J Diabetes Complications; 2021 Mar; 35(3):107828. PubMed ID: 33436143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a complex intervention to promote appropriate prescribing and medication intensification in poorly controlled type 2 diabetes mellitus in Irish general practice.
    Murphy ME; Byrne M; Zarabzadeh A; Corrigan D; Fahey T; Smith SM
    Implement Sci; 2017 Sep; 12(1):115. PubMed ID: 28915897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of therapeutic inertia and the degree of the medication adherence on the control goals for patients with diabetes].
    López-Simarro F; Moral I; Aguado-Jodar A; Cols-Sagarra C; Mancera-Romero J; Alonso-Fernández M; Miravet-Jiménez S; Brotons C
    Semergen; 2018; 44(8):579-585. PubMed ID: 29174068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of type 2 diabetes mellitus in Spain today: identification of the main obstacles in daily clinical practice].
    Torres IV; Donlo IC
    Med Clin (Barc); 2013 Sep; 141 Suppl 2():3-6. PubMed ID: 24444517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to insulin progression among patients with type 2 diabetes: a systematic review.
    Polinski JM; Smith BF; Curtis BH; Seeger JD; Choudhry NK; Connolly JG; Shrank WH
    Diabetes Educ; 2013; 39(1):53-65. PubMed ID: 23192599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic literature review of methodologies used to assess medication adherence in patients with diabetes.
    Clifford S; Perez-Nieves M; Skalicky AM; Reaney M; Coyne KS
    Curr Med Res Opin; 2014 Jun; 30(6):1071-85. PubMed ID: 24432796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of adherence rates by medication class in type 2 diabetes: a study protocol.
    McGovern A; Tippu Z; Hinton W; Munro N; Whyte M; de Lusignan S
    BMJ Open; 2016 Feb; 6(2):e010469. PubMed ID: 26928029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of clinical inertia in patients with type 2 diabetes who were treated with a single oral antidiabetic drug.
    Suzuki R; Kazumori K; Usui T; Shinohara M
    J Diabetes Investig; 2023 Jan; 14(1):81-91. PubMed ID: 36229998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study.
    Heissam K; Abuamer Z; El-Dahshan N
    Pan Afr Med J; 2015; 20():177. PubMed ID: 26113919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient adherence to medication requirements for therapy of type 2 diabetes.
    Bailey CJ; Kodack M
    Int J Clin Pract; 2011 Mar; 65(3):314-22. PubMed ID: 21314869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to diabetes medication: a systematic review.
    Krass I; Schieback P; Dhippayom T
    Diabet Med; 2015 Jun; 32(6):725-37. PubMed ID: 25440507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.